sur The Vanguard Group, Inc. (isin : US12572Q1058)
The Vanguard Group, Inc. Discloses Position in Mural Oncology plc
The Vanguard Group, Inc. has filed a Form 8.3 disclosing its interests in Mural Oncology plc, as per the requirements of the Irish Takeover Panel. The form was filed on September 3, 2025, detailing Vanguard's position on September 2, 2025.
Vanguard owns and controls 771,411 shares, representing 4.47% of the $0.01 ordinary shares in Mural Oncology plc. The filing indicates no cash-settled or stock-settled derivatives held by Vanguard related to these securities.
Recent transactions related to these securities include the sale of 32 shares at $2.08 each. Vanguard confirms no involvement in any indemnity, option arrangements, or agreements concerning these securities.
No supplemental Form 8 has been attached, and no other parties are involved in additional disclosures according to the document.
R. P.
Copyright © 2025 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de The Vanguard Group, Inc.